arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Climb Bio, Inc.

CLYM

$12.52 ▼ -1.68 (-11.83%) at close

27 Visible periods

19 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Climb Bio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $953.4M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -5.1% ↗

FCF / Share $-0.14 ↗

Trailing P/E —

Price / Book 3.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-13.72M

↑ +34.0% —

FCF / Share Free cash flow per share

$-0.14

↑ +16.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-38.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	35.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-46.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	92.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-416.7% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	N/M	13.3% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-852.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	92.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	55.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	59.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	66.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	N/M	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	34.0% Excellent ↑ Excellent Improving Year-over-year change in net income	34.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-108.1% Weak ↑ Weak Improving Year-over-year change in net income	-133.6% Weak ↑ Weak Improving Year-over-year change in net income	62.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-1124.6% Weak ↓ Weak Declining Year-over-year change in net income	-131.1% Weak ↑ Weak Improving Year-over-year change in net income	-124.2% Weak ↑ Weak Improving Year-over-year change in net income	-951.5% Weak ↓ Weak Declining Year-over-year change in net income	92.4% Excellent ↑ Excellent Improving Year-over-year change in net income	53.1% Excellent ↑ Excellent Improving Year-over-year change in net income	59.0% Excellent ↑ Excellent Improving Year-over-year change in net income	64.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-68.8% Weak ↓ Weak Declining Year-over-year change in net income	26.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-0.7% Weak ↑ Weak Improving Year-over-year change in net income	-67.4% Weak ↑ Weak Improving Year-over-year change in net income	29.0% Excellent ↑ Excellent Improving Year-over-year change in net income	29.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-325.8% Weak Weak Year-over-year change in net income	-434.6% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	16.0% Good Good Year-over-year change in free cash flow	7.9% Fair Fair Year-over-year change in free cash flow	—	—	—	-247.6% Weak Weak Year-over-year change in free cash flow	—	—	—	88.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	—	—	-68.3% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.07x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.68x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.5% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	47.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.3% Good Good Return earned on debt + equity capital invested Optimal: > 10%	12.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-11.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-11.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-61.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-5.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-9.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-10.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-11.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-178%)	-11.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-175%)	-10.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-4.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-4.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-24.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-265%)	-1.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-3.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-123%)	-3.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-4.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-19.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	-6.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-7.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-10.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-8.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-157%)	-6.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-142%)	-5.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	17.1% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+14%)	43.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+187%)	59.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+297%)	18.1% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+21%)	16.6% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+11%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Net Debt (USD)	$-44.11M	$-8.36M	$-35.69M	$-25.80M	$-22.68M	$-29.02M	$-87.23M	$-146.18M	$-223.14M	$-105.03M	$-93.11M	$-57.35M	$-25.29M	$-34.44M	$-43.59M	$-35.94M	$-32.60M	$-31.93M	$-46.92M	$-62.82M	—	—	$-20.49M	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-0.18	$-0.20	$-0.25	$-0.19	$-0.13	$-0.31	$0.04	$-0.13	$-1.81	$-0.06	$-0.13	$-0.15	$-0.19	$-0.84	$-0.29	$-0.37	$-0.56	—	$1.25	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.14	$-0.21	—	$-0.18	$-0.16	$-0.23	—	—	—	$-0.07	—	—	—	$-0.57	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.17	$3.10	$3.36	$2.60	$2.75	$2.86	$3.15	$3.25	$3.33	$3.84	$3.88	$4.00	$4.17	$4.33	$4.84	$5.06	$5.35	$5.84	$6.29	$6.74	$-14.57	—	$-7.31	—	—	—	—
Tangible Book Value per Share (USD)	$4.17	$3.10	$3.36	$2.60	$2.75	$2.86	$3.15	$3.25	$3.33	$3.84	$3.88	$4.00	$4.17	$4.33	$4.84	$5.06	$5.35	$5.84	$6.29	$6.74	$-14.57	—	$-7.31	—	—	—	—
Basic Weighted Avg Shares (shares)	76.15M	68.21M	—	68.00M	67.59M	67.46M	—	67.01M	30.35M	27.64M	—	27.07M	26.84M	26.49M	—	26.34M	26.30M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$180.70M	$109.33M	$98.86M	$86.02M	—	$93.24M	$149.94M	$194.19M	$222.26M	$106.27M	$107.42M	$109.53M	$110.63M	$115.26M	$128.30M	$126.89M	$125.46M	$126.39M	$142.22M	$153.04M	$99.09M	—	$18.93M	—	—	—	—
Total Equity (USD)	$239.55M	$148.09M	$160.47M	$177.00M	$185.76M	$193.38M	$211.88M	$218.78M	$222.28M	$106.38M	$107.60M	$109.74M	$112.50M	$116.86M	$128.72M	$134.36M	$142.24M	$155.14M	$167.20M	$176.66M	$-50.84M	$-43.18M	$-24.98M	$-12.48M	$-9.81M	$-7.78M	$-5.56M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$33.00K	$38.00K	$30.00K	$29.00K	$38.00K	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-13.72M	$-13.72M	$-17.52M	$-20.78M	$-20.78M	$-20.78M	$-8.42M	$-8.89M	$-54.89M	$-1.70M	$-3.64M	$-3.97M	$-5.22M	$-22.29M	$-7.76M	$-9.68M	$-14.60M	$-13.20M	$-10.54M	$-9.62M	$-8.72M	$-18.60M	$-14.86M	$-2.26M	$-1.63M	—	—
Operating Cash Flow (USD)	$-10.55M	$-14.38M	$-15.63M	$-12.14M	$-11.15M	$-15.43M	$-5.52M	—	—	$-1.82M	$-947.00K	—	—	$-15.18M	$-8.45M	—	—	$-10.78M	$-7.88M	—	—	$-6.74M	$-5.62M	$-2.38M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 7 years · 27 quarters

Climb Bio, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CLYM with peers